Manulife (Manufacturers Life Insurance)’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $502K | Sell |
38,328
-18,660
| -33% | -$245K | ﹤0.01% | 2176 |
|
2025
Q1 | $1.25M | Buy |
56,988
+16,818
| +42% | +$370K | ﹤0.01% | 1702 |
|
2024
Q4 | $1.07M | Buy |
40,170
+1,760
| +5% | +$47K | ﹤0.01% | 1879 |
|
2024
Q3 | $1.03M | Buy |
38,410
+44
| +0.1% | +$1.17K | ﹤0.01% | 1916 |
|
2024
Q2 | $691K | Buy |
38,366
+7,786
| +25% | +$140K | ﹤0.01% | 2054 |
|
2024
Q1 | $558K | Buy |
30,580
+13,322
| +77% | +$243K | ﹤0.01% | 2163 |
|
2023
Q4 | $189K | Sell |
17,258
-662
| -4% | -$7.24K | ﹤0.01% | 2644 |
|
2023
Q3 | $103K | Buy |
17,920
+192
| +1% | +$1.1K | ﹤0.01% | 2797 |
|
2023
Q2 | $137K | Buy |
17,728
+3,294
| +23% | +$25.5K | ﹤0.01% | 2739 |
|
2023
Q1 | $96.3K | Hold |
14,434
| – | – | ﹤0.01% | 2751 |
|
2022
Q4 | $129K | Buy |
14,434
+1,827
| +14% | +$16.3K | ﹤0.01% | 2726 |
|
2022
Q3 | $124K | Sell |
12,607
-410
| -3% | -$4.03K | ﹤0.01% | 2749 |
|
2022
Q2 | $104K | Sell |
13,017
-2,713
| -17% | -$21.6K | ﹤0.01% | 2896 |
|
2022
Q1 | $153K | Sell |
15,730
-3,204
| -17% | -$31.1K | ﹤0.01% | 2860 |
|
2021
Q4 | $289 | Buy |
+18,934
| New | +$289 | ﹤0.01% | 2622 |
|